Publications by authors named "John B Eleeza"
Background: Serogroup A Neisseria meningitidis was the major cause of meningococcal meningitis epidemics in the African meningitis belt before 2010 when the monovalent meningococcal A conjugate vaccine (MenAfriVac) was introduced in the region. Therefore, this study aimed to establish the trends in N. meningitidis serogroups from 2016 to 2020 in Ghana's meningitis belt.
View Article and Find Full Text PDFArticle Synopsis
- Ghana implemented the 13-valent pneumococcal conjugate vaccine (PCV13) in 2012, achieving over 88% vaccination coverage, but still faced outbreaks of pneumococcal meningitis.
- A study surveyed patients at three hospitals to assess the economic impact of PCV13-type pneumonia and meningitis, finding significant costs incurred by families and healthcare systems.
- The estimated annual economic burden reached $5.2 million, disproportionately affecting costs related to deaths from these diseases, particularly in older children and adults.